Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension | NCT00652483 | Trialant
CompletedInterventionalPhase 3Updated Apr 3, 2008
Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
ClinicalTrials.gov ID
NCT00652483
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
433Actual
Last Update Posted
Apr 3, 2008Estimated
Start Date
May 2003
Primary Completion Date
Dec 2003Actual
Completion Date
Sep 2004Actual
Brief Summary
This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic solution compared with brimonidine 0.2% ophthalmic solution in patients with glaucoma or ocular hypertension